Complement Therapeutics gains IND clearance to begin human testing of its lead gene therapy, CTx001, in patients with geographic atrophy secondary to ...
FDA grants Vivace Therapeutics a fast track designation for its lead cancer drug VT3989, a first-in-class TEAD autopalmitoylation inhibitor for use in...
FDA warns Garland, TX-based Naturich Cosmetique about CGMP violations in its production of finished drugs.
FDA says Trividia Health has recalled 601 blood glucose meters that may have defective LCD displays.
FDA issues Xspray Pharma a complete response letter on its NDA for Dasynoc (dasatinib) and its use for treating chronic myeloid leukemia and acute lym...
A federal judge gives Eli Lilly a partial win in a lawsuit challenging FDAs refusal to classify retatrutide the companys investigational obesity ther...
AstraZeneca says its investigational drug baxdrostat met the primary endpoint in the Phase 3 Bax24 trial in patients with resistant hypertension.
Thirteen Republican House members call on HHS to lay off the CDER director, Office of Generic Drugs director, and others who were behind the approval ...
